Sumitomo Dainippon Pharma Oncology Announces Its Formation Through Merger of Tolero and Boston Biomedical

Sumitomo Dainippon Pharma Oncology Is Positioned to Advance Meaningful Therapies for Patients with Cancer through Innovative Drug Discovery, Research and Development CAMBRIDGE, Mass., July 1, 2020 -- (Healthcare Sales & Marketing Network) -- Sumitomo D... Biopharmaceuticals, Oncology, Mergers & Acquisitions Sumitomo Dainippon Pharma Oncology, Tolero Pharmaceuticals, Boston Biomedical
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news